Webinar
From Software to Science: How Deep Tech Is Reshaping VC
Join Matt Caspari, Managing Partner of Alumni Ventures’ Deep Tech Fund, for a sharp look at why deep tech has moved from venture’s hardest, slowest-moving corner to the category quietly powering its biggest outcomes — and why the next decade of venture returns will be defined by the companies solving civilization-scale technical problems.
In this session, Matt Caspari, Managing Partner of Alumni Ventures’ Deep Tech Fund, will walk through the structural shift reshaping venture capital: the rise of deep tech as the dominant category driving outsized outcomes across the industry. Matt will share how technologies once considered too capital-intensive, too long-cycle, or too technically risky for traditional venture have become the defining stories of the past decade — from AI and biotech, to space, fusion, advanced manufacturing, and the rebuild of U.S. industrial capacity.
The conversation will go beyond the headlines to examine the forces behind this shift — why falling compute costs, breakthrough materials science, defense and infrastructure tailwinds, and a generational rebuild of American hard tech have collapsed the timelines deep tech once required. Matt will discuss how the Deep Tech Fund identifies and underwrites these companies, how the team thinks about risk and milestones in technically ambitious bets, and why deep tech increasingly belongs alongside software in any serious venture allocation.
Whether you’re a current Deep Tech Fund investor sharpening your view of where the asset class is heading, or an accredited investor evaluating frontier technology for the first time, this session will give you a grounded, investor-focused thesis on one of the most important shifts happening in venture today. Register to hear directly from the team building a portfolio around it.
Want to access our Deep Tech Syndicate startup deals to see, evaluate, and optionally invest? No cost, no commitment.
Why Attend?
- HomeDiscover why deep tech has gone from venture's hardest category to one of its most consequential return drivers
- HomeUnderstand the structural shifts — compute economics, defense and infrastructure tailwinds, industrial rebuild — that have collapsed deep tech's traditional timelines
- HomeLearn how the Deep Tech Fund identifies, underwrites, and builds a portfolio around the companies solving civilization-scale technical problems
Rated a Top 20 VC Firm by both TIME and CB Insights.
Alumni Ventures is America’s largest venture capital firm for individual investors.
About your presenter
Overview
Matt Caspari invests in mission-driven founders building the next generation of iconic companies—entrepreneurs tackling the world’s hardest, highest-stakes problems. He backs breakthrough technologies with the potential to redefine critical industries, unlock new markets, and create a more sustainable, secure future.
Before Alumni Ventures, Matt was a two-time venture-backed founder/CEO and a leader of the innovation team at Nike. He founded Aurora Biofuels, a deep-tech venture that grew to 100+ employees and secured more than $100 million in funding before its acquisition by Reliance Industries. Earlier, he advised life science multinationals at Cambridge Pharma Consultancy (acquired by IMS Health) and gained experience on Bloomberg’s M&A team. Matt holds a BS in Biochemistry from Georgetown University and an MBA with a Certificate in Entrepreneurship from UC Berkeley.
Funds actively worked on
Investment Area of Focus
His investment lens favors bold solutions to global challenges and durable advantages rooted in technology and aligned with long-term megatrends. This translates to surgical robots powered by physical AI, next-generation energy systems, space-based infrastructure, longevity therapeutics, and more. The through-line is the potential for extraordinary value creation at the intersection of deep science and global need.
Representative investments Matt has led for Alumni Ventures include Andromeda Surgical and Cytronic (Physical AI); Arda Therapeutics and Cambrian Biopharma (Technologies for the Human Body); Max Space and Orbital Operations (Space Infrastructure); and Fortera and Mainspring Energy (The New Energy Stack). Alumni Ventures’ Deep Tech portfolio also includes companies such as Axiom Space, Ayar Labs, Cohere, Frore Systems, Groq, Hawkeye360, Hayden AI, Lambda, Radiant, and Rigetti (Nasdaq: RGTI).